Optune Lua: The Newest Advancement in Tumor Treating Fields Technology for Malignant Pleural Mesothelioma
In May, Optune Lua became the first FDA-approved Tumor Treating Fields device designed for use with standard dual-drug chemotherapy for
In May, Optune Lua became the first FDA-approved Tumor Treating Fields device designed for use with standard dual-drug chemotherapy for